Human NK cells and their receptors

Area of Science:

• Immunology
• Cellular Biology
• Transplantation Medicine

Background:

• Recent advances have elucidated natural killer (NK) cell functions, particularly their recognition of target cells via MHC-specific inhibitory receptors.
• Identification of activating receptors suggests roles in natural cytotoxicity and pathogen recognition.
• A subset of CD8(+) T lymphocytes exhibits NK-like activity through TCR alpha/beta recognition of HLA-E, distinct from NK cell triggering receptors.

Purpose of the Study:

• To review the progress in understanding natural killer (NK) cell function over the past decade.
• To explore the mechanisms of NK cell-mediated cytotoxicity, including inhibitory and activating receptors.
• To discuss the therapeutic potential of NK cells, especially in bone marrow transplantation.

Main Methods:

• Review of recent literature on NK cell biology and function.
• Analysis of receptor-mediated recognition processes in NK cells and CD8(+) T lymphocytes.
• Examination of clinical data regarding NK cell activity in bone marrow transplantation.

Main Results:

• NK cells utilize MHC-specific inhibitory receptors to identify and eliminate abnormal cells.
• Activating receptors on NK cells contribute to cytotoxicity and may recognize pathogen-associated molecular patterns.
• Alloreactive NK cells generated during haploidentical bone marrow transplantation can prevent leukemia relapse, graft rejection, and graft-versus-host disease.

Conclusions:

• Understanding NK cell function, particularly their receptor repertoire, is crucial for their therapeutic application.
• The exploitation of HLA class I mismatches to activate NK cells represents a significant advancement in bone marrow transplantation strategies.
• NK cell-based therapies hold revolutionary potential for treating hematological malignancies and improving transplant outcomes.